Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS

• by Caihong Qu, Xiaoying Wang

• May 1, 2026

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

• by İlkay Çıtakkul, Yasemin Bakkal Temi, Ece Baydar, Elif Şahin, Umut Kefeli, Devrim Çabuk, Kazım Uygun

• May 29, 2026

Editorial: Overcoming resistance to immune checkpoint inhibitors: mechanisms and strategies in cancer therapy

• by Margherita Piccinelli, Elio Gregory Pizzutilo, Maria Gemelli, Dhifaf Sarhan, Stefano Cavalieri

• May 6, 2026

Digital Health in Pediatric Neurology: From Episodic to Continuous Care

Digital health has emerged as a transformative force in 21st-century medicine, reshaping the boundaries of healthcare delivery.

• by

• May 12, 2026

• 4 min